Differential surface marker expression in patients with CD-16+ lymphoproliferative disorders: in vivo model for NK differentiation.
Differential surface marker expression in patients with CD-16+ lymphoproliferative disorders: in vivo model for NK differentiation. Hum Immunol. 1987 Jun; 19(2):105-15.